ALFA FinderNSE filing, NSE: M&M. Summary written from the filing by ALFA Finder's alert engine.
Mahindra & Mahindra Ltd: key numbers
- Share price
- ₹3,287.20
- Market cap
- ₹4,08,773 Cr
- Revenue (annual)
- ₹1,98,639 Cr
- Net profit (annual)
- ₹17,099 Cr
- P/E (TTM)
- 21.1×Sector 32.4×
- Promoter holding
- 18.39%-0.06% QoQ
- FII holding
- 33.34%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mahindra & Mahindra Ltd
All →Mahindra & Mahindra Capital Structure Change
Mahindra & Mahindra will subscribe in cash to the proposed rights issue of its listed subsidiary SML Mahindra, up to Rs. 1,450 crore. No change in control of SML is envisaged.
- Value
- ₹1,450 Cr
Mahindra & Mahindra Earnings Call Transcript: Key Takeaways
Consolidated revenue ₹57,553 Cr (+25%) and PAT ₹4,588 Cr (+25%) on multi-business strength, despite commodity inflation, monsoon deficit and a cut tractor outlook.
Mahindra & Mahindra Management Change
Ms. Shuchi Suri will transition from Executive Vice-President, Mahindra Experiences to Chief Sales & Marketing Officer - Automotive Business. She ceases being Senior Management Personnel effective April 1, 2027.
Mahindra & Mahindra Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue Rs 57,553 cr (+25%) and PAT Rs 4,588 cr (+25%). H1 PAT +29%, H1 EPS Rs 89.5, annualised RoE 21%.
Mahindra & Mahindra Results Update
Mahindra & Mahindra reported a 25% increase in Q2 F27 consolidated PAT to ₹4,588 Crore. Revenue for the period reached ₹57,553 Crore, driven by strong growth in the automotive sector.
- Value
- ₹57,553 Cr
Mahindra & Mahindra Q2 FY27 Results: Net Profit ₹5,167 Cr, Up 30.3% YoY
Mahindra & Mahindra Ltd reported revenue from operations of ₹57,515 Cr (+25.3% YoY) and net profit of ₹5,167 Cr (+30.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹5,167 Cr · +30.3% YoY
Other product launch announcements
All →AstraZeneca Pharma India Product Launch
AstraZeneca Pharma India will launch Datverzo, Datopotamab Deruxtecan, in India in November 2026. The drug holds DCGI import and market permission for HR-positive, HER2-negative breast cancer.
Raama Finance Product Launch
Raama Finance launched 'Rupya Lelo', a digital lending platform offering instant personal loans, on October 6, 2026. The product is available only in India, and no loan amount or financial figure is disclosed.
Puravankara Product Launch
Puravankara will launch the residential project Purva Cityspire Phases 1, 2 and 3 in Ernakulam on 15 November 2026. The project is RERA-registered and is being developed by two wholly owned subsidiaries.
JBM Auto Product Launch
JBM Electric Vehicles launched the all-electric ECOLIFE e12 city bus at Singapore Urban Mobility Week 2026. It cites 20,000-bus annual capacity and a new Singapore APAC hub.
- electric bus manufacturing capacity
- 20000.0 buses per annum
Restaurant Brands Asia Product Launch
Burger King India launches a limited-edition Avengers: Doomsday Collection across nationwide restaurants. The menu features themed burgers, sides, and merchandise starting at ₹199.
Hero MotoCorp Product Launch
Hero MotoCorp unveiled new motorcycles at EICMA 2026 and started VIDA customer deliveries across Europe. The company also introduced Novus Labs, its future-mobility innovation hub.